Výsledky vyhledávání

Akademický článek

Case report: Favorable efficacy of combined afatinib and anlotinib treatment in a lung adenocarcinoma patient harboring uncommon EGFR L858M/L861R mutations

Autor: Yueming He, Yitao Wu, Rongqi He, Meng Xu, Heshan Chen, Yiran Meng, Liuqing Zheng, Li Wang

Publikováno v: Frontiers in Pharmacology, Vol 15 (2024)

Targeted therapy has significantly prolonged survival of non-small cell lung cancer (NSCLC) patients carrying common EGFR mutations, but the standard care for patients with rare mutations has not been well established. Here, we report a 65-year-old f

Externí odkaz: https://doaj.org/article/c3516f4e5e5c4619a54017a205d6b243

Zobrazit plný text záznamu

Akademický článek

Lobectomy versus segmentectomy for stage IA3 (T1cN0M0) non-small cell lung cancer: a meta-analysis and systematic review

Autor: Wanfei Zhang, Shaogeng Chen, Xianzuan Lin, Hongbo Chen, Rongqi He

Publikováno v: Frontiers in Oncology, Vol 13 (2023)

BackgroundSegmentectomy has been proven to have better survival and perioperative efficacy than lobectomy for non-small cell lung cancer (NSCLC) up to 2 cm. Whether this result is applicable to stage T1cN0M0 NSCLC (2.1 to 3 cm) remains controversial.

Externí odkaz: https://doaj.org/article/55fd8f4ec3054f53819099b072e0f8ef

Zobrazit plný text záznamu

PTMA binds to HMGB1 to regulate mitochondrial oxidative phosphorylation and thus affect the malignant progression of esophageal squamous cell carcinoma

Autor: Shaogeng Chen, Rongqi He, Xianzuan Lin, Wanfei Zhang, Heshan Chen, Rongyu Xu, Mingqiang Kang

Publikováno v: Journal of Thoracic Disease. 15:1302-1318

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::351a19ed4039d4933faf105f604bcbf3
https://doi.org/10.21037/jtd-23-143

Zobrazit plný text záznamu

Akademický článek

Serum-Derived Exosomes MicroRNA-923 and MicroRNA-523 Expression to Regulate Autophagy in Esophageal Squamous Cell Carcinoma.

Autor: CHEN, H., RONGYU XU, RONGQI HE, CHEN, S., FU, J., HONGBO CHEN, XIANGKUN DU

Publikováno v: Indian Journal of Pharmaceutical Sciences; Mar/Apr2024, Vol. 86 Issue 2, p484-493, 10p

Zobrazit plný text záznamu

PHLDA3 activated by BARX2 transcription, suppresses the malignant development of esophageal squamous cell carcinoma by downregulating PI3K/AKT levels

Autor: Shaogeng Chen, Xianzuan Lin, Rongqi He, Wanfei Zhang, Mingqiang Kang, Rongyu Xu

Publikováno v: Experimental Cell Research. 426:113567

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9a2aadd495daab14d3b9ed8efb8a88b0
https://doi.org/10.1016/j.yexcr.2023.113567

Zobrazit plný text záznamu

Reduced miR-203 predicts metastasis and poor survival in esophageal carcinoma

Autor: Jiabin Du, Weinan Liu, Rongqi He, Kai Ye, Jintian Wang, Junxing Chen

Publikováno v: Aging (Albany NY)

We analyzed data from two non-coding RNA profiling arrays made available by the Gene Expression Omnibus (GEO) and found 17 miRNAs with remarkable differential expression between malignant and normal esophageal tissue. Correlation analysis between exp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de2eda0c1355c8f1e377df4c1ee8b30
http://europepmc.org/articles/PMC6949080

Zobrazit plný text záznamu

Real-world clinical effectiveness and safety of camrelizumab in esophageal squamous cell carcinoma

Autor: Yuyi Lin, Liangyun Ma, Jianli Huang, Rongqi He, Jiancheng Li, Shouguo Li, Zhichao Fu, Qiwei Yao, Jintong Wu, Qisong Chen, Chunlin Ke

Publikováno v: Journal of Clinical Oncology. 39:e16023-e16023

e16023 Background: Camrelizumab, a programmed death 1 (PD-1) inhibitor, has recently demonstrated efficacy for esophageal squamous cell carcinoma (ESCC) patients in a phase III trial. We report real-world clinical outcomes of camrelizumab therapy for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::163d6e9fb7f0d3e1576dfed1986c8ffb
https://doi.org/10.1200/jco.2021.39.15_suppl.e16023

Zobrazit plný text záznamu

Correlation analysis between polymorphism of GSTP1, XPD and XRCC1 gene in esophageal carcinoma patients and treatment efficiency of cisplatin chemo-therapy

Autor: Rongqi He, Huiyan Xiao, Shaogeng Chen, Heshan Chen, Xu Li

Publikováno v: Biomedical Research. 29

Objective: As a common malignant tumor, esophageal carcinoma lacked specific clinical symptoms, leading to distal metastasis at terminal stage. Cisplatin is the first-line chemotherapy drug for the treatment of esophageal cancer. Identification of se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0c7c5f06a8fe5d493281c2c6c528c423
https://doi.org/10.4066/biomedicalresearch.29-17-1223

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání